We have collected information about 118 children born to mothers who were given lithium treatment during the first trimester of pregnancy. The data show that the risk of teratogenic effects is lower than one might have expected from some of the studies carried out on rats and mice; they do not answer the question of whether or not lithium is teratogenic in man. The data were collected retrospectively and therefore overestimate rather than underestimate the risk of teratogenicity. Introduction It has been known for many years that lithium (lithium salts, lithium ions) added to the medium surrounding eggs of sea urchins, snails, and other lower organisms may interfere with morphogenesis so that monsters are produced (Herbst, 1893; Schou, 1957 
Introduction
It has been known for many years that lithium (lithium salts, lithium ions) added to the medium surrounding eggs of sea urchins, snails, and other lower organisms may interfere with morphogenesis so that monsters are produced (Herbst, 1893; Schou, 1957) . Teratogenic lithium effects have also been shown in mammals. Szabo (1970) administered lithium by gavage to pregnant mice and induced cleft palate in up to 30% of the young. Wright et al. (1971) gave lithium intraperitoneally to pregnant rats and found cleft palate in 39% of the young, external ear defects in 45%, and eye defects in 63%. Other studies with the same and different animal species (rabbits, monkeys) (Bass et al., 1951; Trautner et al., 1958; Johansen and Ulrich, 1969; Johansen, 1971; Schluter, 1971; Gralla and Mcllhenny, 1972) .
The prophylactic effect of lithium in recurrent manicdepressive disorder has been known for some time Schou and Baastrup, 1967) , and an increasing number of patients are being given lithium maintenance treatment. Among those treated are women in the fertile age range, and since some of these become pregnant the question arises whether lithium administration to pregnant women carries the same high risk of congenital malformations as that observed in some of the animal studies.
In order to detect such a lithium effect as soon as possible we began some years ago to collect information about children born of lithium-treated women. The information could have been collected in different ways. One way would have been to use a prospective procedure where a number of women given lithium during the pregnancy were followed and the outcome of their pregnancies recorded. Another way was to work retrospectively and record "lithium babies" (see below) as they came to the notice of the Register of Lithium Babies. We chose the latter procedure because it had the best chance of giving early warning if the risk of teratogenicity was as high as indicated by the studies of Szabo (1970) and Wright et al. (1971) .
A warning of this kind did not emerge from the data. Since we have now recorded more than a hundred lithium babies, we feel the time has come to report our findings.
Procedure
The Register of Lithium Babies started on a Scandinavian basis, but soon reports also arrived from outside Scandinavia. During the past few years information has been collected in the United States and Canada.
The existence of the Register has been announced through notes published at intervals in psychiatric and general medical journals. These notes urged physicians to submit reports about lithium babies, normal or abnormal, that might come to their notice. A "lithium baby" was defined as a child born of a woman who had been treated with lithium during the first trimester of pregnancy. Congenital malformations were defined as macroscopic abnormalities of structure attributable to faulty development and present at birth (McKeown and Record, 1960 tFive of these were malformed and appear also in that group. §Both mothers were in their late thirties.
Discussion
The information was collected retrospectively, and one must therefore expect an over-representation of abnormalities among the reports. A lithium baby is more likely to be recognized as such and reported to the Register if it is stillborn or malformed or dies soon after birth than if it is alive and normal in every respect. Little attention may be paid to drugs taken during the pregnancy by mothers of normal and healthy children, whereas the birth of an abnormal child almost certainly leads to inquiries on this point. Incomplete and selective reporting is therefore probable. In our material there is a much higher frequency of congenital malformations among the reports from countries outside Scandinavia than among those from the Scandinavian countries. Since, as indicated above, the contact with physicians Lewis and Suris (1970) .
tReported by Vacaflor et al. (1970) and Aoki and Ruedy (1971) .
outside Scandinavia has been less close than with those inside Scandinavia, reports from the former are more likely to be incomplete and selective than reports from the latter.
It is accordingly likely that the frequencies of stillbirth, congenital malformations, and other anomalies in our material are higher than the true frequencies among children of lithiumtreated women, and it is unlikely that they are lower. We are therefore on safe ground when we compare the frequency of malformations in our material with the frequency found in the studies of Szabo (1970) and Wright et al. (1971) . The comparison shows that the risk of malformations among children of women given lithium during pregnancy is much lower than that indicated by the animal studies. Whether the risk is the same as or higher than the risk among children of women not given lithium we cannot tell. To answer that question one must use a different procedure.
The aim of the Register of Lithium Babies was to give early warning if the risk of teratogenic effects was as high in women as it was in some of the studies carried out in rats and mice.
A large number of reports have now shown that it is not. Two of us (Schou and 
